4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000130
Chairperson & CEO sold 9,500 shares at an average $522.57 ($4,964,376)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
19 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-08-27 | Sale : show line 2 in the form 10b5-1 | −494 | $511.58 | $252,718 | 333,449 | I |
| 2026-08-27 | Sale : show line 3 in the form 10b5-1 | −642 | $512.47 | $329,007 | 332,807 | I |
| 2026-08-27 | Sale : show line 4 in the form 10b5-1 | −704 | $513.40 | $361,434 | 332,103 | I |
| 2026-08-27 | Sale : show line 5 in the form 10b5-1 | −120 | $514.32 | $61,718 | 331,983 | I |
| 2026-08-27 | Sale : show line 6 in the form 10b5-1 | −240 | $515.33 | $123,679 | 331,743 | I |
| 2026-08-27 | Sale : show line 7 in the form 10b5-1 | −280 | $517.07 | $144,780 | 331,463 | I |
| 2026-08-27 | Sale : show line 8 in the form 10b5-1 | −200 | $518.89 | $103,779 | 331,263 | I |
| Open-market sales · 9,500 sh · avg $522.57 · $4,964,376 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-27 | Exercise or conversion : show line 20 in the form 10b5-1 Stock Option | −9,500 | 46,910 | I |
Loading xslF345X06/primarydocument.xml…